Drug development requires the efforts of a broad set of disciplines as well as nonclinical, clinical, regulatory and commercial experts. An integrated strategy that considers innovative trial designs and patient centricity can improve efficiency, reduce costs, and shorten development timelines.
- The importance of integrating clinical and regulatory strategies
- Approaches to new clinical trial designs and technologies
- Patient centricity inclusion throughout the development process
- Traits to look for in CRO partners